<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">JMIR Res Protoc</journal-id><journal-id journal-id-type="iso-abbrev">JMIR Res Protoc</journal-id><journal-id journal-id-type="publisher-id">ResProt</journal-id><journal-title-group><journal-title>JMIR Research Protocols</journal-title></journal-title-group><issn pub-type="epub">1929-0748</issn><publisher><publisher-name>JMIR Publications</publisher-name><publisher-loc>Toronto, Canada</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40340957</article-id><article-id pub-id-type="pmc">PMC12099273</article-id><article-id pub-id-type="publisher-id">v14i1e67570</article-id><article-id pub-id-type="doi">10.2196/67570</article-id><article-categories><subj-group subj-group-type="heading"><subject>Protocol</subject></subj-group><subj-group subj-group-type="article-type"><subject>Protocol</subject></subj-group></article-categories><title-group><article-title>Metabolic Flexibility to Predict Lifestyle Interventions Outcomes (MEPHISTO): Protocol for Predictive Validation Study and Randomized Controlled Trial</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Schwartz</surname><given-names>Amy</given-names></name></contrib><contrib contrib-type="editor"><name><surname>Sarvestan</surname><given-names>Javad</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Bipat</surname><given-names>Robbert</given-names></name></contrib><contrib contrib-type="reviewer"><name><surname>Wooldridge</surname><given-names>Jennalee S</given-names></name></contrib></contrib-group><contrib-group><contrib id="contrib1" contrib-type="author" equal-contrib="yes"><name><surname>Ludlova</surname><given-names>Monika</given-names></name><degrees>MSc</degrees><xref rid="aff1" ref-type="aff">1</xref><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0008-6796-4847</contrib-id></contrib><contrib id="contrib2" contrib-type="author" equal-contrib="yes"><name><surname>Koudelkov&#x000e1;</surname><given-names>Kate&#x00159;ina</given-names></name><degrees>MD</degrees><xref rid="aff2" ref-type="aff">2</xref><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2053-9698</contrib-id></contrib><contrib id="contrib3" contrib-type="author" equal-contrib="yes"><name><surname>Pallova</surname><given-names>Jitka</given-names></name><degrees>MD</degrees><xref rid="aff2" ref-type="aff">2</xref><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0002-2971-1845</contrib-id></contrib><contrib id="contrib4" contrib-type="author" equal-contrib="yes"><name><surname>Koudelkova</surname><given-names>Barbora</given-names></name><degrees>BS</degrees><xref rid="aff2" ref-type="aff">2</xref><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0006-1027-8518</contrib-id></contrib><contrib id="contrib5" contrib-type="author" equal-contrib="yes"><name><surname>Siklova</surname><given-names>Michaela</given-names></name><degrees>ING, PhD</degrees><xref rid="aff3" ref-type="aff">3</xref><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0489-1069</contrib-id></contrib><contrib id="contrib6" contrib-type="author" equal-contrib="yes"><name><surname>Cahova</surname><given-names>Monika</given-names></name><degrees>RNDr, PhD</degrees><xref rid="aff4" ref-type="aff">4</xref><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2640-5084</contrib-id></contrib><contrib id="contrib7" contrib-type="author" equal-contrib="yes"><name><surname>Vetrovsky</surname><given-names>Tomas</given-names></name><degrees>MD, PhD</degrees><xref rid="aff1" ref-type="aff">1</xref><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2529-7069</contrib-id></contrib><contrib id="contrib8" contrib-type="author" corresp="yes" equal-contrib="yes"><name><surname>Steffl</surname><given-names>Michal</given-names></name><degrees>PhD</degrees><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7297-8145</contrib-id><xref rid="aff1" ref-type="aff">1</xref><address><institution>Faculty of Physical Education and Sport</institution><institution>Charles University</institution><addr-line>Jos&#x000e9; Mart&#x000ed;ho 31</addr-line><addr-line>Prague, 16000</addr-line><country>Czech Republic</country><phone>420 778701882</phone><email>michal.steffl@ftvs.cuni.cz</email></address></contrib><contrib id="contrib9" contrib-type="author" equal-contrib="yes"><name><surname>Gojda</surname><given-names>Jan</given-names></name><degrees>MD, PhD</degrees><xref rid="aff2" ref-type="aff">2</xref><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7995-5947</contrib-id></contrib></contrib-group><aff id="aff1">
<label>1</label>
<institution>Faculty of Physical Education and Sport</institution>
<institution>Charles University</institution>
<addr-line>Prague</addr-line>
<country>Czech Republic</country>
</aff><aff id="aff2">
<label>2</label>
<institution>Clinical Research Department</institution>
<institution>Kralovske Vinohrady University Hospital and Third Faculty of Medicine</institution>
<institution>Charles University</institution>
<addr-line>Prague</addr-line>
<country>Czech Republic</country>
</aff><aff id="aff3">
<label>3</label>
<institution>Department of Pathophysiology, Centre for Research on Diabetes, Metabolism and Nutrition</institution>
<institution>Third Faculty of Medicine</institution>
<institution>Charles University</institution>
<addr-line>Prague</addr-line>
<country>Czech Republic</country>
</aff><aff id="aff4">
<label>4</label>
<institution>First Faculty of Medicine</institution>
<institution>Institute of Clinical and Experimental Medicine</institution>
<addr-line>Prague</addr-line>
<country>Czech Republic</country>
</aff><author-notes><corresp>Corresponding Author: Michal Steffl <email>michal.steffl@ftvs.cuni.cz</email></corresp></author-notes><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>8</day><month>5</month><year>2025</year></pub-date><volume>14</volume><elocation-id>e67570</elocation-id><history><date date-type="received"><day>15</day><month>10</month><year>2024</year></date><date date-type="rev-request"><day>31</day><month>1</month><year>2025</year></date><date date-type="rev-recd"><day>15</day><month>2</month><year>2025</year></date><date date-type="accepted"><day>24</day><month>3</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9;Monika Ludlova, Kate&#x00159;ina Koudelkov&#x000e1;, Jitka Pallova, Barbora Koudelkova, Michaela Siklova, Monika Cahova, Tomas Vetrovsky, Michal Steffl, Jan Gojda. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 08.05.2025.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (<ext-link xlink:href="https://creativecommons.org/licenses/by/4.0/" ext-link-type="uri">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Research Protocols, is properly cited. The complete bibliographic information, a link to the original publication on <ext-link xlink:href="https://www.researchprotocols.org" ext-link-type="uri">https://www.researchprotocols.org</ext-link>, as well as this copyright and license information must be included.</license-p></license></permissions><self-uri xlink:href="https://www.researchprotocols.org/2025/1/e67570"/><abstract><sec sec-type="background"><title>Background</title><p>Weight loss is a cornerstone of obesity treatment and diabetes mellitus type 2 (T2D) prevention, but its implementation in clinical practice is limited by its perceived burden and variability in response. Personalizing interventions to increase their success rate is an unmet clinical need.</p></sec><sec sec-type="objective"><title>Objective</title><p>Identification of predictive factors associated with successful weight loss after sequential exercise in women with obesity.</p></sec><sec sec-type="methods"><title>Methods</title><p>The study will consist of a 2-stage analytical approach, including a predictive validation study and a 2:1 randomized cross-over controlled trial. Women aged 25-45 years with obesity (BMI&#x0003e;30) will be included in the study. The intervention will consist of a progressive protocol of aerobic exercise on a treadmill and a bicycle ergometer. We will measure weight loss in terms of fat mass (FM) and fat-free mass (FFM), metabolic flexibility (MetFlex) as &#x00394;RQ (change in respiratory quotient (VCO2/VO2) between basal and insulin-stimulated state during glucose clamp), insulin sensitivity, glucose tolerance, hemoglobin A<sub>1c</sub>, microbiome composition, and metabolomic signatures.</p></sec><sec sec-type="results"><title>Results</title><p>Recruitment for the trial began in January 2024. A total of 12 participants were enrolled and randomized. Among them 6 participants have completed the first phase of the A-arm and 6 participants have completed the control period of the B-arm and their intervention is ongoing. Recruitment is ongoing. We expect the preliminary data from this study to be completed in 2026.</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>This intervention will investigate whether whole body and gut MetFlex can be further explored and used as ex ante predictors of successful weight loss following exercise intervention, providing proof of concept and paving the way for personalized lifestyle interventions.</p></sec><sec sec-type="Trial Registration"><title>Trial Registration</title><p>ClinicalTrials.gov NCT06329349; https://clinicaltrials.gov/study/NCT06329349</p></sec><sec sec-type="registered-report"><title>International Registered Report Identifier (IRRID)</title><p>DERR1-10.2196/67570</p></sec></abstract><kwd-group><kwd>obesity</kwd><kwd>overweight</kwd><kwd>weight loss</kwd><kwd>physical activity</kwd><kwd>exercise</kwd><kwd>gut microbiota</kwd><kwd>metabolic flexibility</kwd><kwd>diabetes</kwd><kwd>endocrinology</kwd><kwd>validation study</kwd><kwd>randomized control trial</kwd><kwd>protocol</kwd></kwd-group></article-meta></front><body><sec sec-type="introduction"><title>Introduction</title><p>Obesity has reached pandemic proportions and is a major risk factor for type 2 diabetes (T2D), cardiovascular disease, and other metabolic disorders. Prevention progression to T2D in individuals with obesity through effective lifestyle interventions is a public health priority Substantial and sustained weight loss achieved through lifestyle modifications is a key strategy to reduce the risk of T2D and improve metabolic health [<xref rid="ref1" ref-type="bibr">1</xref>,<xref rid="ref2" ref-type="bibr">2</xref>]. The most effective lifestyle interventions aim to achieve a negative net energy balance through two key principles: increasing physical activity and reducing caloric intake. The health benefits associated with regular physical activity are closely linked to the systemic adaptive responses elicited by each training session [<xref rid="ref3" ref-type="bibr">3</xref>]. Similarly, the beneficial effects of weight loss induced by hypocaloric diets depend on complex adipose tissue remodeling [<xref rid="ref4" ref-type="bibr">4</xref>]. However, detailed analysis of clinical trial data reveals substantial interindividual variability in responses to these interventions, leading to differences in their effectiveness and health benefits [<xref rid="ref5" ref-type="bibr">5</xref>,<xref rid="ref6" ref-type="bibr">6</xref>].</p><p>This highlights the need for more personalized lifestyle interventions tailored to individual phenotypes. Recent studies have emphasized phenotype-based interventions as a promising strategy [<xref rid="ref7" ref-type="bibr">7</xref>,<xref rid="ref8" ref-type="bibr">8</xref>], particularly focusing on behavioral phenotypes and maladaptive eating patterns in patients with obesity. However, the physiological determinants that may influence weight loss success remain underexplored.</p><p>Among the influential determinants that affect the effectiveness and health outcomes of an intervention is an individual&#x02019;s level of metabolic flexibility (MetFlex). MetFlex refers to the body's ability to adapt in response to changes in metabolic demands and nutrient availability [<xref rid="ref9" ref-type="bibr">9</xref>]. Impaired MetFlex is a hallmark of obesity and T2D but can be improved by lifestyle interventions such as exercise training or caloric restriction [<xref rid="ref9" ref-type="bibr">9</xref>-<xref rid="ref11" ref-type="bibr">11</xref>], similar to improvements in insulin sensitivity. Despite this, MetFlex has not been systematically investigated as a potential mechanism underlying successful weight loss. Impaired MetFlex, that is the limited ability of cells or tissues to cope with excess or deficiency of energy substrates, leads to impaired mitochondrial function and excessive lipid accumulation in ectopic tissues, resulting in metabolic disorders such as T2D or metabolic syndrome.</p><p>Another potential predictor of an individual&#x02019;s ability to respond to lifestyle interventions is the gut microbiota (gut microbiome and metabolome [MIME]). It has repeatedly been shown to be one of the most important sources of interindividual variability in the development of obesity [<xref rid="ref12" ref-type="bibr">12</xref>] and also responsiveness to weight loss interventions [<xref rid="ref13" ref-type="bibr">13</xref>]. The microbiome not only influences host physiology directly, for example through contact with immune cells, but also through the large number of metabolites produced, that is, the microbiota-derived metabolome [<xref rid="ref14" ref-type="bibr">14</xref>]. The composition of the gut microbiota and the microbiota-derived metabolome is largely determined by the host&#x02019;s diet, which is the main source of nutrients and energy for the microbiota [<xref rid="ref15" ref-type="bibr">15</xref>]. It is therefore striking that published studies to date have yielded rather inconsistent results regarding dietary interventions to alter gut microbiota composition [<xref rid="ref16" ref-type="bibr">16</xref>]. This discrepancy can be explained by the large variability of individual microbiomes at the start of the intervention, and also by the fact that the baseline MIME signature is a significant determinant of weight loss success.</p><p>Here we propose a comprehensive project MEPHISTO (MEtabolic flexibility to Predict Health lIfeSTyle intervention Outcomes) to investigate whether whole-body and gut MetFlex can be further explored and used as ex ante predictors of successful weight loss following exercise intervention. By identifying key physiological and microbial signatures, this research aims to provide a basis for personalized obesity treatment strategies, ultimately improving diabetes prevention efforts.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Design</title><p>A randomized, cross-over, controlled clinical trial will be conducted at Charles University in Prague, Czech Republic. The study will consist of a two-stage analytical approach that will be used to obtain specific results:</p><p>1. The first stage is a predictive validation study where we will compare changes in fat mass (FM)/ fat-free mass (FFM) weight loss (after an intervention - predictor variable) with baseline characteristics (independent variable) in the whole sample (n=40). The expected results are the identification of baseline characteristics associated with total and FM/FFM weight loss after the intervention.</p><p>2. The second phase is a 2:1 randomized cross-over control trial where we will investigate the effects of the progressive aerobic exercise intervention protocol on MetFlex, metabolic adaptation, and insulin sensitivity. As an exploratory outcome, the fecal metabolomic response will be analyzed.</p></sec><sec><title>Participants</title><p>Women aged 25-45 years with obesity (BMI&#x0003e;30) are included in the study. Only female participants were selected to reduce heterogeneity, as MetFlex and energy metabolism are sex-dependent and to improve statistical power in a small sample. This selection aligns with previous studies at our research center and will allow for future data pooling. Practical considerations, including shared facilities and standardized protocols, also supported this decision.</p></sec><sec><title>Inclusion and Exclusion Criteria</title><p>The inclusion and exclusion criteria are mentioned in <xref rid="box1" ref-type="boxed-text">Textbox 1</xref>.</p><boxed-text id="box1" position="float"><caption><title>Inclusion and exclusion criteria.</title></caption><p>
<bold>Inclusion criteria</bold>
</p><p>Participants who meet the following criteria will be eligible for the study:</p><p>&#x02022; BMI&#x0003e;30</p><p>&#x02022; Age 25-45 years</p><p>
<bold>Exclusion criteria</bold>
</p><p>&#x02022; Active cancer</p><p>&#x02022; Diabetes (medical history, fasting glycemia &#x0003e;7.6, and glycemia of &#x0003e;11.1 on the 2-hour oral glucose tolerance test)</p><p>&#x02022; Uncontrolled endocrine diseases</p><p>&#x02022; Corticosteroid therapy</p><p>&#x02022; Immune-suppressive therapy</p><p>&#x02022; Pregnancy</p><p>&#x02022; Breastfeeding</p></boxed-text></sec><sec><title>Recruitment Process</title><p>Potential volunteers will be recruited from outpatients and previous research participants at the Department of Internal Medicine, University Hospital Kralovsk&#x000e9; Vinohrady, Prague, or through social media advertising via the university and hospital platforms. Our research participant network is only used to advertise studies, and individuals who have previously participated in interventional trials will not be included. In addition, patients from the Obesitology Centre will be considered only before their enrollment in clinical interventional programs to prevent previous interventions from influencing study outcomes.</p></sec><sec><title>Allocation</title><p>After screening for eligibility, a baseline clinical examination will be performed to assess the inclusion and exclusion criteria and to ensure weight stability for 12 weeks before enrollment. Participants will then be randomized by an independent investigator to either exercise intervention arm A or exercise intervention and control arm B using a computer-generated random number table.</p><p>After the baseline visit 1 examination, the A-arm will undergo 12 weeks of a progressive aerobic exercise intervention protocol, after which the clinical examination will be repeated. Participants in the B-arm will be assessed after 12 weeks of no intervention and then crossed over to the exercise intervention, after which the final clinical assessment will be carried out (<xref rid="figure1" ref-type="fig">Figure 1</xref>).</p><fig position="float" id="figure1"><label>Figure 1</label><caption><p>Enrollment, intervention, and evaluation project schedule.</p></caption><graphic xlink:href="resprot_v14i1e67570_fig1" position="float"/></fig></sec><sec><title>Intervention</title><p>The exercise intervention is designed according to the 2021 European Association for the Study of Obesity (EASO) guidelines to maximize the effect of reducing body weight and adipose tissue [<xref rid="ref17" ref-type="bibr">17</xref>]. These guidelines recommend 150 to 200 minutes of at least moderate-intensity aerobic exercise (Grade A). The exercise intervention will last 12 weeks, during which the study participants will perform aerobic endurance exercise 3 times a week in groups of 6 people under supervision.</p><p>The exercise will be performed as fast walking on a treadmill. The duration and intensity of the exercise will be controlled so that the energy expenditure per unit of exercise is 150 kcal in the first week, increasing by 50 kcal each week thereafter until week 6 when it reaches 400 kcal, a level that will be maintained until the end of the intervention [<xref rid="ref18" ref-type="bibr">18</xref>]. The walking pace will be adjusted individually, based on input of indirect calorimetry, to correspond to moderate intensity physical activity (metabolic equivalent of task 3 to 6) and to achieve the required energy expenditure in the given time. A progressive increase in energy expenditure during the intervention will be therefore ensured by an appropriate combination of increasing intensity and duration of exercise. For this reason, the duration of each session will be individual, for example, 30 minutes of walking at a speed of 5 km/hour corresponds to approximately 180 kcal for a person weighing 95 kg [<xref rid="ref19" ref-type="bibr">19</xref>].</p><p>During the intervention, participants&#x02019; compliance will be strictly monitored: if a session is missed, it will be made up as soon as possible. If more than one session is missed (eg, due to illness), the intervention will be extended to make up for the missed sessions, but not more than 2 weeks. Only participants who complete at least 90% of the training sessions will be included in the analysis (so they can skip a maximum of 3 sessions).</p></sec><sec><title>Primary Outcome Measures</title><p>Stage 1: the relationship between FM/FFM weight loss and baseline characteristics of MetFlex, calculated as the change in respiratory quotient (&#x00394;RQ).</p><p>Stage 2: change in MetFlex, defined as the &#x00394;RQ between basal and insulin-stimulated state during glucose clamp examination, and change in insulin sensitivity (glucose infusion rate).</p></sec><sec><title>Secondary Outcome Measures</title><p>Changes in glucose tolerance (glucose level on the 2-hour oral glucose tolerance test), hemoglobin A<sub>1c</sub>, and insulin sensitivity (glucose infusion rate) following the intervention will be evaluated following the intervention.</p></sec><sec><title>Exploratory Outcome Measures</title><p>Changes in microbiome composition and metabolomic signatures will also be assessed following the intervention.</p></sec><sec><title>Data Collection</title><sec><title>Anthropometry</title><p>The anthropometric measures used were weight, height, bioimpedance analysis (TANITA MC-980U Plus Multi-Frequency Segmental Body Composition Analyzer, manufacturer, state), DXA (Hologic&#x02019;s Horizon DXA Platform), and plethysmography (BOD POD&#x02019;s Air Displacement Plethysmography Cosmed).</p></sec><sec><title>Indirect Calorimetry</title><p>The resting gas exchange will be measured using a canopy hood ventilated system with a metabolic cart (Quark RMR, Cosmed). Standard air, gas, and flow calibrations will be performed before each measurement. Important deviations may limit the reliability of measurements, to correct for this postcalorimetric simulation with high-precision mass flow regulators (EL-Flow Prestige, Bronkhorst high-tech B.V., NL) will be done after each measurement with a defined gas mixture. VO<sub>2</sub>, VCO<sub>2,</sub> and nitrogen loss per 24 hours will be used to calculate basal substrate utilization of carbohydrates, fat, and protein.</p></sec><sec><title>Oral Glucose Tolerance Test</title><p>A standard 75 g oral glucose tolerance test will be performed with blood sampling at 0, 30, 60, 90, and 120 minutes. The test will assess dynamic changes in substrate metabolism, including &#x00394;RQ shifts over time (120&#x02013;60&#x02013;0 min) and changes in circulating free fatty acids (&#x00394;FFA), glucose, and insulin levels in response to the glucose load.</p></sec><sec><title>Hyperinsulinemic-Euglycemic Clamp</title><p>A 2-step hyperinsulinemic-euglycemic clamp will be conducted over 200 minutes, with insulin infusion rates of 10 and 40 mIU/m&#x000b2;, each maintained for 100 minutes. This will be followed by a 100-minute tapering period of glucose infusion after insulin discontinuation. The primary outcomes will include &#x00394;RQ (at 300&#x02013;250&#x02013;200&#x02013;100&#x02013;0 min), free fatty acid suppression (&#x00394;FFA), and glucose infusion rate (&#x00394;GIR) as markers of insulin sensitivity and MetFlex.</p></sec><sec><title>Maximal Oxygen Uptake Test</title><p>A graded maximal exercise test will be performed on a bicycle ergometer (Ergoline GmbH) using a ramp protocol with an incremental workload increase of 15 W/min. Gas exchange parameters will be measured continuously via spiroergometry (Quark RMR), and electrocardiogram monitoring will be conducted throughout the test. The primary outcomes (maximal oxygen uptake [VO&#x02082;max], heart rate, and peak power output), will be used to individualize the exercise intervention protocol.</p></sec><sec><title>Diet Record</title><p>Each participant will provide a 3-day diet record before the intervention or control period, once during the period, and then after the completion of the intervention or control. Nutrixo (Arcai Health) software with validated food composition databases will be used to calculate dietary intakes.</p></sec><sec><title>Metagenomics Analysis of Gut Microbiota</title><p>The microorganism populations present in the stool samples will be assessed by shallow shotgun sequencing using NovaSeq ox NextSeq Illumina platform targeting sequencing depth of approximately 1 million reads or samples. Demultiplexing, BAM and FASTQ file generation will be performed using the Picard suite (Broad Institute). Quality-filtered metagenomes will be taxonomically profiled using MetaPhlAn3 (Metagenomic Phylogenetic Analysis) with default parameters.</p></sec><sec><title>Untargeted Analysis of Serum Metabolome</title><p>Serum metabolite spectrum will be determined using NMR-based methods. Serum samples will be analyzed on Bruker AVANCE III 600 MHz and 700 MHz spectrometers according to the standard protocols. Metabolites will be identified by comparison with spectral databases (BBIOREFCODE, Chenomx, HMDB [Human Metabolome Database]) and published assignments. Liquid chromatography&#x02013;mass spectrometry analysis in serum extracts will be performed using previously optimized procedures including extraction, separation by liquid chromatography (Agilent 1200), and detection by Bruker MS spectrometer micrOTOF-Q III. Suitable conditions will allow identification per exact mass, retention time, isotopic pattern, and fragmentations. For this purpose, Bruker software and MZmine 2.17 will be used.</p></sec></sec><sec><title>Data Analysis and Statistical Considerations</title><p>To assess the effectiveness of the weight loss intervention and identify key predictors of response, such as microbiome, metabolomic profiles, and demographics, we will use generalized mixed effects models. These models account for both fixed effects (the intervention and relevant covariates) and individual variability, providing a robust analysis of the impact of the intervention. In addition, we will develop elastic net-based predictive models, complemented by machine learning algorithms, to stratify individuals into intervention groups, with the secondary aim of identifying responders. These models will be subjected to rigorous validation, including cross-validation or bootstrapping, to ensure their accuracy and generalizability. This approach aims not only to determine the efficacy of the intervention but also to improve personalized treatment by accurately classifying individuals based on their unique profiles, thereby advancing the field of personalized medicine. The analyses will be performed using IBM SPSS Statistics and R statistical packages.</p></sec><sec><title>Sample Size</title><p>Sample size considerations will be based on the power to address the primary hypothesis. The main predictor variables for the sample are &#x00394;RQ (200-0) and glucose disposal (mg/kg/min). In recent observations from our TRIEMA (Treatment of Insulin Resistance: a Personalized Approach) study (NCT03710850), glucose disposal was 6.6 (SD 2.1), while &#x00394;RQ was 0.05 (SD 0.04). The dependent variable, the expected weight loss after the intervention, is 4 (SD 5) kg [<xref rid="ref20" ref-type="bibr">20</xref>]. The 30-subject study will have 80% power to detect a difference in weight loss of 4 kg (which is a clinically significant 5% weight loss for a woman weighing 80 kg at a difference of &#x00394;RQ=0.07 (calculated using the PWRSS library in the R environment), at a probability level of <italic>&#x003b1;</italic>=.05. We plan to enroll 40 women to allow for attrition to the end of the intervention without risk of losing statistical power.</p></sec><sec><title>Major Confounders</title><p>It is known from the literature that people who start a structured exercise program may experience behavioral compensation in the form of increased food intake [<xref rid="ref21" ref-type="bibr">21</xref>] and reduced habitual physical activity in everyday life [<xref rid="ref22" ref-type="bibr">22</xref>,<xref rid="ref23" ref-type="bibr">23</xref>]. Therefore, in our study, we will monitor participants&#x02019; caloric intake using repeated 24-hour recalls and physical activity using an accelerometer. Caloric intake and habitual physical activity will always be assessed (1) in the week before the exercise intervention, (2) in the 6th week of the intervention, that is, after reaching the target energy expenditure, and (3) in the last 12th week of the intervention. In each of these weeks, caloric intake is assessed using 24-hour menu records from 3 specific days (the day of exercise, a weekday without exercise, and the weekend), using an application that works with validated food composition tables [<xref rid="ref24" ref-type="bibr">24</xref>]. The caloric intake for each of the 3 weeks will be calculated from these 3 days.</p><p>Physical activity will be assessed in each of the specified weeks using the Axivity AX3 accelerometer. The accelerometer will be attached to the participant&#x02019;s wrist and worn within 24 hours for 7 full days. The data from the accelerometer will be processed using the GGIR library in R and the volume (average acceleration) and intensity (intensity gradient) of physical activity [<xref rid="ref25" ref-type="bibr">25</xref>] will be calculated for each of the 3 weeks.</p><p>Compensation will be calculated as the difference between caloric intake or physical activity during the intervention (average of weeks 6 and 12) and before the intervention.</p></sec><sec><title>Feasibility Consideration</title><p>The team has extensive experience in conducting clinical trials and all methods are routinely available in the team members&#x02019; facilities. Therefore, we do not anticipate any feasibility issues. We anticipate difficulties in recruitment and enrollment due to the challenging protocol and strict inclusion and exclusion criteria and anticipate a buffer time in the timetable for up to double the recruitment of participants. In case of an emergency situation that would make it impossible to carry out the clinical trial (such as the experience during the COVID-19 pandemic), we plan to work within work package 2 with databases and biobank material from previous studies that would allow the project outputs.</p></sec><sec><title>Ethical Considerations</title><p>The institutional review board of the University Hospital (EK-VP/28/1/2022) and the Faculty of Physical Education and Sport of Charles University (218/2023) reviewed the protocol before recruitment, and all participants will sign an informed consent form before enrollment. The study will be conducted in accordance with the Declaration of Helsinki and GCP.</p><p>The study will be conducted in accordance with the Declaration of Helsinki and Good Clinical Practice (GCP). The protocol was reviewed by the institutional ethics committee of University Hospital Kralovske Vinohrady and the Faculty of Physical Education and Sport Charles University.</p></sec></sec><sec sec-type="results"><title>Results</title><p>Recruitment for the trial began in January 2024. A total of 12 participants were enrolled and randomized. Among them, 6 participants have completed the first phase of the A-arm and 6 participants have completed the control period of the B-arm and their intervention is ongoing. Recruitment is ongoing. We expect the preliminary data from this study to be completed in 2026. This clinical trial protocol was developed based on the SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) 2013 Statement [<xref rid="ref26" ref-type="bibr">26</xref>] (<xref rid="app1" ref-type="supplementary-material">Multimedia Appendix 1</xref>).</p></sec><sec sec-type="discussion"><title>Discussion</title><p>This randomized trial will assess the strength of predictive factors associated with successful weight loss after an exercise intervention in women with obesity. By focusing on both whole-body and gut MetFlex, the study aims to elucidate key mechanisms that contribute to individual variability in weight loss outcomes. The findings have the potential to lead to the development of more personalized and effective weight loss treatments, filling a critical gap in current obesity and diabetes management.</p><p>Several key decisions were made in the design of this clinical trial to overcome limitations in existing literature and reduce potential bias. One such decision is the use of a cross-over trial design, which enhances the robustness of the study by allowing participants to serve as their own controls. This approach helps reduce interindividual variability and provides stronger evidence of the causal relationship between the interventions and the observed outcomes.</p><p>Lifestyle interventions, particularly those combining dietary and exercise components, are as essential for managing and potentially reversing diabetes progression [<xref rid="ref27" ref-type="bibr">27</xref>,<xref rid="ref28" ref-type="bibr">28</xref>]. Substantial evidence supports the role of sustained weight loss in improving insulin sensitivity, glycemic control, and other metabolic outcomes. However, the heterogeneity in response to such interventions highlights a critical need for personalization [<xref rid="ref29" ref-type="bibr">29</xref>,<xref rid="ref30" ref-type="bibr">30</xref>]. Individuals vary widely in their ability to lose weight and maintain that loss, which is often attributed to differences in MetFlex, the gut microbiome, and behavioral adaptations [<xref rid="ref31" ref-type="bibr">31</xref>]. An additional strength of this study is the comprehensive monitoring of participants&#x02019; dietary intake and physical activity throughout the intervention. By accounting for compensatory behaviors, such as changes in caloric intake or reduced physical activity outside of exercise sessions, we aim to provide a clearer understanding of how these factors contribute to weight loss variability.</p><p>However, some limitations need to be considered. The strict eligibility criteria may make recruitment challenging, potentially limiting generalizability to the broader population of women with obesity. Furthermore, while compensatory behaviors are monitored, other factors such as psychological and social influences could still impact outcomes.</p><p>In conclusion, this trial will provide important insights into the role of MetFlex and the gut microbiome in predicting successful weight loss. These findings could lead to more personalized interventions in clinical practice, ultimately improving adherence and outcomes in obesity and diabetes management.</p></sec></body><back><ack><p>The investigators would like to express their sincere appreciation for the valuable contributions of the participants. This work is supported by the Grant Agency of the Ministry of Health, Czech Republic (grant NU23-01-00509), and by grants from Charles University Cooperation and Grant Agency of Charles University (grant 74524). The funding agencies have no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.</p><p>During the preparation of this work, the authors used ChatGPT in order to improve readability and language. After using this tool or service, the authors reviewed and edited the content as needed and took full responsibility for the content of the publication.</p></ack><fn-group><fn fn-type="con"><p>Authors' Contributions: ML, JP, and BK performed investigation. ML and MS contributed to writing the original draft. KK, MC, and JG contributed to conceptualization. MS and JG contributed to funding acquisition. TV contributed to methodology. MS and JG performed supervision. MS, KK, and JG contributed to writing, review and editing.</p></fn><fn fn-type="COI-statement"><p>Conflicts of Interest: None declared.</p></fn></fn-group><app-group><supplementary-material id="app1" position="float" content-type="local-data"><label>Multimedia Appendix 1</label><p>SPIRIT checklist.</p><media xlink:href="resprot_v14i1e67570_app1.pdf" xlink:title="PDF File (Adobe PDF File), 233 KB" id="d100e522" position="anchor"/></supplementary-material></app-group><glossary><title>Abbreviations</title><def-list><def-item><term id="abb1">EASO</term><def><p>European Association for the Study of Obesity</p></def></def-item><def-item><term id="abb2">FFM</term><def><p>fat-free mass</p></def></def-item><def-item><term id="abb3">FM</term><def><p>fat mass</p></def></def-item><def-item><term id="abb4">HMDB</term><def><p>Human Metabolome Database</p></def></def-item><def-item><term id="abb5">MEPHISTO</term><def><p>Metabolic flexibility to Predict Health Lifestyle Intervention Outcomes</p></def></def-item><def-item><term id="abb6">MetaPhlAn3</term><def><p>Metagenomic Phylogenetic Analysis</p></def></def-item><def-item><term id="abb7">MetFlex</term><def><p>metabolic flexibility</p></def></def-item><def-item><term id="abb8">MIME</term><def><p>gut microbiome and metabolome</p></def></def-item><def-item><term id="abb9">SPIRIT</term><def><p>Standard Protocol Items: Recommendations for Interventional Trials</p></def></def-item><def-item><term id="abb10">T2D</term><def><p>type 2 diabetes</p></def></def-item><def-item><term id="abb11">VO&#x02082;max</term><def><p>maximal oxygen uptake</p></def></def-item><def-item><term id="abb12">&#x00394;FFA</term><def><p>changes in circulating free fatty acids</p></def></def-item><def-item><term id="abb13">&#x00394;GIR</term><def><p>change in glucose infusion rate</p></def></def-item><def-item><term id="abb14">&#x00394;RQ</term><def><p>change in respiratory quotient</p></def></def-item></def-list></glossary><notes><sec sec-type="data-availability"><title>Data Availability</title><p>The datasets generated or analyzed during this study are available from the corresponding author on reasonable request.</p></sec></notes><ref-list><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>You</surname><given-names>W</given-names></name><name><surname>Almeida</surname><given-names>F</given-names></name><name><surname>Estabrooks</surname><given-names>P</given-names></name><name><surname>Davy</surname><given-names>B</given-names></name></person-group><article-title>The effectiveness and cost of lifestyle interventions including nutrition education for diabetes prevention: a systematic review and meta-analysis</article-title><source>J Acad Nutr Diet</source><year>2017</year><volume>117</volume><issue>3</issue><fpage>404</fpage><lpage>421.e36</lpage><comment>
<ext-link xlink:href="https://europepmc.org/abstract/MED/28236962" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1016/j.jand.2016.11.016</pub-id><pub-id pub-id-type="medline">28236962</pub-id><pub-id pub-id-type="pii">S2212-2672(16)31451-4</pub-id><!--<pub-id pub-id-type="pmcid">PMC5330213</pub-id>--><pub-id pub-id-type="pmid">28236962</pub-id>
</element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>American Diabetes Association Professional Practice Committee</collab></person-group><article-title>8. Obesity and weight management for the prevention and treatment of type 2 diabetes: standards of care in diabetes-2024</article-title><source>Diabetes Care</source><year>2024</year><volume>47</volume><issue>Suppl 1</issue><fpage>S145</fpage><lpage>S157</lpage><pub-id pub-id-type="doi">10.2337/dc24-S008</pub-id><pub-id pub-id-type="medline">38078578</pub-id><pub-id pub-id-type="pii">153942</pub-id><!--<pub-id pub-id-type="pmcid">PMC10725806</pub-id>--><pub-id pub-id-type="pmid">38078578</pub-id>
</element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>D</given-names></name><name><surname>Karpe</surname><given-names>F</given-names></name><name><surname>Lafontan</surname><given-names>M</given-names></name><name><surname>Frayn</surname><given-names>K</given-names></name></person-group><article-title>Physical activity and exercise in the regulation of human adipose tissue physiology</article-title><source>Physiol Rev</source><year>2012</year><volume>92</volume><issue>1</issue><fpage>157</fpage><lpage>191</lpage><comment>
<ext-link xlink:href="https://journals.physiology.org/doi/10.1152/physrev.00012.2011?url_ver=Z39.88-2003&#x00026;rfr_id=ori:rid:crossref.org&#x00026;rfr_dat=cr_pub0pubmed" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1152/physrev.00012.2011</pub-id><pub-id pub-id-type="medline">22298655</pub-id><pub-id pub-id-type="pii">92/1/157</pub-id><pub-id pub-id-type="pmid">22298655</pub-id>
</element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossmeislov&#x000e1;</surname><given-names>L</given-names></name><name><surname>Malisov&#x000e1;</surname><given-names>L</given-names></name><name><surname>Kracmerov&#x000e1;</surname><given-names>J</given-names></name><name><surname>Tencerov&#x000e1;</surname><given-names>M</given-names></name><name><surname>Kov&#x000e1;cov&#x000e1;</surname><given-names>Z</given-names></name><name><surname>Koc</surname><given-names>M</given-names></name><name><surname>Siklov&#x000e1;-V&#x000ed;tkov&#x000e1;</surname><given-names>M</given-names></name><name><surname>Viquerie</surname><given-names>N</given-names></name><name><surname>Langin</surname><given-names>D</given-names></name><name><surname>Stich</surname><given-names>V</given-names></name></person-group><article-title>Weight loss improves the adipogenic capacity of human preadipocytes and modulates their secretory profile</article-title><source>Diabetes</source><year>2013</year><volume>62</volume><issue>6</issue><fpage>1990</fpage><lpage>1995</lpage><comment>
<ext-link xlink:href="https://europepmc.org/abstract/MED/23378611" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.2337/db12-0986</pub-id><pub-id pub-id-type="medline">23378611</pub-id><pub-id pub-id-type="pii">db12-0986</pub-id><!--<pub-id pub-id-type="pmcid">PMC3661637</pub-id>--><pub-id pub-id-type="pmid">23378611</pub-id>
</element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>King</surname><given-names>NA</given-names></name><name><surname>Hopkins</surname><given-names>M</given-names></name><name><surname>Caudwell</surname><given-names>P</given-names></name><name><surname>Stubbs</surname><given-names>RJ</given-names></name><name><surname>Blundell</surname><given-names>JE</given-names></name></person-group><article-title>Individual variability following 12 weeks of supervised exercise: identification and characterization of compensation for exercise-induced weight loss</article-title><source>Int J Obes (Lond)</source><year>2008</year><volume>32</volume><issue>1</issue><fpage>177</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1038/sj.ijo.0803712</pub-id><pub-id pub-id-type="medline">17848941</pub-id><pub-id pub-id-type="pii">0803712</pub-id><pub-id pub-id-type="pmid">17848941</pub-id>
</element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>S&#x000e1;ez de Asteasu</surname><given-names>ML</given-names></name><name><surname>Mart&#x000ed;nez-Velilla</surname><given-names>N</given-names></name><name><surname>Zambom-Ferraresi</surname><given-names>F</given-names></name><name><surname>Casas-Herrero</surname><given-names>&#x000c1;</given-names></name><name><surname>Cadore</surname><given-names>EL</given-names></name><name><surname>Ramirez-Velez</surname><given-names>R</given-names></name><name><surname>Izquierdo</surname><given-names>M</given-names></name></person-group><article-title>Inter-individual variability in response to exercise intervention or usual care in hospitalized older adults</article-title><source>J Cachexia Sarcopenia Muscle</source><year>2019</year><volume>10</volume><issue>6</issue><fpage>1266</fpage><lpage>1275</lpage><comment>
<ext-link xlink:href="https://europepmc.org/abstract/MED/31407876" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1002/jcsm.12481</pub-id><pub-id pub-id-type="medline">31407876</pub-id><!--<pub-id pub-id-type="pmcid">PMC6903436</pub-id>--><pub-id pub-id-type="pmid">31407876</pub-id>
</element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cifuentes</surname><given-names>L</given-names></name><name><surname>Ghusn</surname><given-names>W</given-names></name><name><surname>Feris</surname><given-names>F</given-names></name><name><surname>Campos</surname><given-names>A</given-names></name><name><surname>Sacoto</surname><given-names>D</given-names></name><name><surname>De la Rosa</surname><given-names>A</given-names></name><name><surname>McRae</surname><given-names>A</given-names></name><name><surname>Rieck</surname><given-names>T</given-names></name><name><surname>Mansfield</surname><given-names>S</given-names></name><name><surname>Ewoldt</surname><given-names>J</given-names></name><name><surname>Friend</surname><given-names>J</given-names></name><name><surname>Grothe</surname><given-names>K</given-names></name><name><surname>Lennon</surname><given-names>RJ</given-names></name><name><surname>Hurtado</surname><given-names>MD</given-names></name><name><surname>Clark</surname><given-names>MM</given-names></name><name><surname>Camilleri</surname><given-names>M</given-names></name><name><surname>Hensrud</surname><given-names>DD</given-names></name><name><surname>Acosta</surname><given-names>A</given-names></name></person-group><article-title>Phenotype tailored lifestyle intervention on weight loss and cardiometabolic risk factors in adults with obesity: a single-centre, non-randomised, proof-of-concept study</article-title><source>EClinicalMedicine</source><year>2023</year><volume>58</volume><fpage>101923</fpage><comment>
<ext-link xlink:href="https://linkinghub.elsevier.com/retrieve/pii/S2589-5370(23)00100-1" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1016/j.eclinm.2023.101923</pub-id><pub-id pub-id-type="medline">37007741</pub-id><pub-id pub-id-type="pii">S2589-5370(23)00100-1</pub-id><!--<pub-id pub-id-type="pmcid">PMC10050763</pub-id>--><pub-id pub-id-type="pmid">37007741</pub-id>
</element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Dai</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name><name><surname>Peng</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name></person-group><article-title>Personalized optimal nutrition lifestyle for self obesity management using metaalgorithms</article-title><source>Sci Rep</source><year>2022</year><volume>12</volume><issue>1</issue><fpage>12387</fpage><comment>
<ext-link xlink:href="https://doi.org/10.1038/s41598-022-16260-w" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1038/s41598-022-16260-w</pub-id><pub-id pub-id-type="medline">35858966</pub-id><pub-id pub-id-type="pii">10.1038/s41598-022-16260-w</pub-id><!--<pub-id pub-id-type="pmcid">PMC9297061</pub-id>--><pub-id pub-id-type="pmid">35858966</pub-id>
</element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmer</surname><given-names>BF</given-names></name><name><surname>Clegg</surname><given-names>DJ</given-names></name></person-group><article-title>Metabolic flexibility and its impact on health outcomes</article-title><source>Mayo Clin Proc</source><year>2022</year><volume>97</volume><issue>4</issue><fpage>761</fpage><lpage>776</lpage><comment>
<ext-link xlink:href="https://linkinghub.elsevier.com/retrieve/pii/S0025-6196(22)00042-8" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1016/j.mayocp.2022.01.012</pub-id><pub-id pub-id-type="medline">35287953</pub-id><pub-id pub-id-type="pii">S0025-6196(22)00042-8</pub-id><pub-id pub-id-type="pmid">35287953</pub-id>
</element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergouignan</surname><given-names>A</given-names></name><name><surname>Antoun</surname><given-names>E</given-names></name><name><surname>Momken</surname><given-names>I</given-names></name><name><surname>Schoeller</surname><given-names>DA</given-names></name><name><surname>Gauquelin-Koch</surname><given-names>G</given-names></name><name><surname>Simon</surname><given-names>C</given-names></name><name><surname>Blanc</surname><given-names>S</given-names></name></person-group><article-title>Effect of contrasted levels of habitual physical activity on metabolic flexibility</article-title><source>J Appl Physiol (1985)</source><year>2013</year><volume>114</volume><issue>3</issue><fpage>371</fpage><lpage>379</lpage><comment>
<ext-link xlink:href="https://journals.physiology.org/doi/10.1152/japplphysiol.00458.2012?url_ver=Z39.88-2003&#x00026;rfr_id=ori:rid:crossref.org&#x00026;rfr_dat=cr_pub0pubmed" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1152/japplphysiol.00458.2012</pub-id><pub-id pub-id-type="medline">23239872</pub-id><pub-id pub-id-type="pii">japplphysiol.00458.2012</pub-id><pub-id pub-id-type="pmid">23239872</pub-id>
</element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huffman</surname><given-names>KM</given-names></name><name><surname>Redman</surname><given-names>LM</given-names></name><name><surname>Landerman</surname><given-names>LR</given-names></name><name><surname>Pieper</surname><given-names>CF</given-names></name><name><surname>Stevens</surname><given-names>RD</given-names></name><name><surname>Muehlbauer</surname><given-names>MJ</given-names></name><name><surname>Wenner</surname><given-names>BR</given-names></name><name><surname>Bain</surname><given-names>JR</given-names></name><name><surname>Kraus</surname><given-names>VB</given-names></name><name><surname>Newgard</surname><given-names>CB</given-names></name><name><surname>Ravussin</surname><given-names>E</given-names></name><name><surname>Kraus</surname><given-names>WE</given-names></name></person-group><article-title>Caloric restriction alters the metabolic response to a mixed-meal: results from a randomized, controlled trial</article-title><source>PLoS One</source><year>2012</year><volume>7</volume><issue>4</issue><fpage>e28190</fpage><comment>
<ext-link xlink:href="https://dx.plos.org/10.1371/journal.pone.0028190" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1371/journal.pone.0028190</pub-id><pub-id pub-id-type="medline">22523532</pub-id><pub-id pub-id-type="pii">PONE-D-11-13098</pub-id><!--<pub-id pub-id-type="pmcid">PMC3327714</pub-id>--><pub-id pub-id-type="pmid">22523532</pub-id>
</element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maruvada</surname><given-names>P</given-names></name><name><surname>Leone</surname><given-names>V</given-names></name><name><surname>Kaplan</surname><given-names>LM</given-names></name><name><surname>Chang</surname><given-names>EB</given-names></name></person-group><article-title>The human microbiome and obesity: moving beyond associations</article-title><source>Cell Host Microbe</source><year>2017</year><volume>22</volume><issue>5</issue><fpage>589</fpage><lpage>599</lpage><comment>
<ext-link xlink:href="https://linkinghub.elsevier.com/retrieve/pii/S1931-3128(17)30440-7" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1016/j.chom.2017.10.005</pub-id><pub-id pub-id-type="medline">29120742</pub-id><pub-id pub-id-type="pii">S1931-3128(17)30440-7</pub-id><pub-id pub-id-type="pmid">29120742</pub-id>
</element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Ni</surname><given-names>Y</given-names></name><name><surname>Cheung</surname><given-names>CKY</given-names></name><name><surname>Lam</surname><given-names>KSL</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Xia</surname><given-names>Z</given-names></name><name><surname>Ye</surname><given-names>D</given-names></name><name><surname>Guo</surname><given-names>J</given-names></name><name><surname>Tse</surname><given-names>MA</given-names></name><name><surname>Panagiotou</surname><given-names>G</given-names></name><name><surname>Xu</surname><given-names>A</given-names></name></person-group><article-title>Gut microbiome fermentation determines the efficacy of exercise for diabetes prevention</article-title><source>Cell Metab</source><year>2020</year><volume>31</volume><issue>1</issue><fpage>77</fpage><lpage>91.e5</lpage><comment>
<ext-link xlink:href="https://linkinghub.elsevier.com/retrieve/pii/S1550-4131(19)30608-4" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1016/j.cmet.2019.11.001</pub-id><pub-id pub-id-type="medline">31786155</pub-id><pub-id pub-id-type="pii">S1550-4131(19)30608-4</pub-id><pub-id pub-id-type="pmid">31786155</pub-id>
</element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname><given-names>RL</given-names></name><name><surname>Holscher</surname><given-names>HD</given-names></name></person-group><article-title>Fueling gut microbes: a review of the interaction between diet, exercise, and the gut microbiota in athletes</article-title><source>Adv Nutr</source><year>2021</year><volume>12</volume><issue>6</issue><fpage>2190</fpage><lpage>2215</lpage><comment>
<ext-link xlink:href="https://linkinghub.elsevier.com/retrieve/pii/S2161-8313(22)00500-2" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1093/advances/nmab077</pub-id><pub-id pub-id-type="medline">34229348</pub-id><pub-id pub-id-type="pii">S2161-8313(22)00500-2</pub-id><!--<pub-id pub-id-type="pmcid">PMC8634498</pub-id>--><pub-id pub-id-type="pmid">34229348</pub-id>
</element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riedl</surname><given-names>RA</given-names></name><name><surname>Atkinson</surname><given-names>SN</given-names></name><name><surname>Burnett</surname><given-names>CML</given-names></name><name><surname>Grobe</surname><given-names>JL</given-names></name><name><surname>Kirby</surname><given-names>JR</given-names></name></person-group><article-title>The gut microbiome, energy homeostasis, and implications for hypertension</article-title><source>Curr Hypertens Rep</source><year>2017</year><volume>19</volume><issue>4</issue><fpage>27</fpage><comment>
<ext-link xlink:href="https://europepmc.org/abstract/MED/28316052" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1007/s11906-017-0721-6</pub-id><pub-id pub-id-type="medline">28316052</pub-id><pub-id pub-id-type="pii">10.1007/s11906-017-0721-6</pub-id><!--<pub-id pub-id-type="pmcid">PMC5773096</pub-id>--><pub-id pub-id-type="pmid">28316052</pub-id>
</element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>From the American Association of Neurological Surgeons (AANS)&#x0201a; American Society of Neuroradiology (ASNR)&#x0201a; CardiovascularInterventional Radiology Society of Europe (CIRSE)&#x0201a; Canadian Interventional Radiology Association (CIRA)&#x0201a; Congress of Neurological Surgeons (CNS)&#x0201a; European Society of Minimally Invasive Neurological Therapy (ESMINT)&#x0201a; European Society of Neuroradiology (ESNR)&#x0201a; European Stroke Organization (ESO)&#x0201a; Society for Cardiovascular AngiographyInterventions (SCAI)&#x0201a; Society of Interventional Radiology (SIR)&#x0201a; Society of NeuroInterventional Surgery (SNIS)&#x0201a;World Stroke Organization (WSO)</collab><name><surname>Sacks</surname><given-names>D</given-names></name><name><surname>Baxter</surname><given-names>B</given-names></name><name><surname>Campbell</surname><given-names>BCV</given-names></name><name><surname>Carpenter</surname><given-names>JS</given-names></name><name><surname>Cognard</surname><given-names>C</given-names></name><name><surname>Dippel</surname><given-names>D</given-names></name><name><surname>Eesa</surname><given-names>M</given-names></name><name><surname>Fischer</surname><given-names>U</given-names></name><name><surname>Hausegger</surname><given-names>K</given-names></name><name><surname>Hirsch</surname><given-names>JA</given-names></name><name><surname>Shazam Hussain</surname><given-names>M</given-names></name><name><surname>Jansen</surname><given-names>O</given-names></name><name><surname>Jayaraman</surname><given-names>MV</given-names></name><name><surname>Khalessi</surname><given-names>AA</given-names></name><name><surname>Kluck</surname><given-names>BW</given-names></name><name><surname>Lavine</surname><given-names>S</given-names></name><name><surname>Meyers</surname><given-names>PM</given-names></name><name><surname>Ramee</surname><given-names>S</given-names></name><name><surname>R&#x000fc;fenacht</surname><given-names>DA</given-names></name><name><surname>Schirmer</surname><given-names>CM</given-names></name><name><surname>Vorwerk</surname><given-names>D</given-names></name></person-group><article-title>Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke</article-title><source>Int J Stroke</source><year>2018</year><volume>13</volume><issue>6</issue><fpage>612</fpage><lpage>632</lpage><pub-id pub-id-type="doi">10.1177/1747493018778713</pub-id><pub-id pub-id-type="medline">29786478</pub-id><pub-id pub-id-type="pmid">29786478</pub-id>
</element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oppert</surname><given-names>J</given-names></name><name><surname>Bellicha</surname><given-names>A</given-names></name><name><surname>van Baak</surname><given-names>MA</given-names></name><name><surname>Battista</surname><given-names>F</given-names></name><name><surname>Beaulieu</surname><given-names>K</given-names></name><name><surname>Blundell</surname><given-names>JE</given-names></name><name><surname>Carra&#x000e7;a</surname><given-names>EV</given-names></name><name><surname>Encantado</surname><given-names>J</given-names></name><name><surname>Ermolao</surname><given-names>A</given-names></name><name><surname>Pramono</surname><given-names>A</given-names></name><name><surname>Farpour-Lambert</surname><given-names>N</given-names></name><name><surname>Woodward</surname><given-names>E</given-names></name><name><surname>Dicker</surname><given-names>D</given-names></name><name><surname>Busetto</surname><given-names>L</given-names></name></person-group><article-title>Exercise training in the management of overweight and obesity in adults: synthesis of the evidence and recommendations from the European Association for the Study of Obesity Physical Activity Working Group</article-title><source>Obes Rev</source><year>2021</year><volume>22</volume><issue>Suppl 4</issue><fpage>e13273</fpage><comment>
<ext-link xlink:href="https://europepmc.org/abstract/MED/34076949" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1111/obr.13273</pub-id><pub-id pub-id-type="medline">34076949</pub-id><!--<pub-id pub-id-type="pmcid">PMC8365734</pub-id>--><pub-id pub-id-type="pmid">34076949</pub-id>
</element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donnelly</surname><given-names>JE</given-names></name><name><surname>Honas</surname><given-names>JJ</given-names></name><name><surname>Smith</surname><given-names>BK</given-names></name><name><surname>Mayo</surname><given-names>MS</given-names></name><name><surname>Gibson</surname><given-names>CA</given-names></name><name><surname>Sullivan</surname><given-names>DK</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Herrmann</surname><given-names>SD</given-names></name><name><surname>Lambourne</surname><given-names>K</given-names></name><name><surname>Washburn</surname><given-names>RA</given-names></name></person-group><article-title>Aerobic exercise alone results in clinically significant weight loss for men and women: midwest exercise trial 2</article-title><source>Obesity (Silver Spring)</source><year>2013</year><volume>21</volume><issue>3</issue><fpage>E219</fpage><lpage>E228</lpage><comment>
<ext-link xlink:href="https://europepmc.org/abstract/MED/23592678" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1002/oby.20145</pub-id><pub-id pub-id-type="medline">23592678</pub-id><!--<pub-id pub-id-type="pmcid">PMC3630467</pub-id>--><pub-id pub-id-type="pmid">23592678</pub-id>
</element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Browning</surname><given-names>RC</given-names></name><name><surname>Kram</surname><given-names>R</given-names></name></person-group><article-title>Energetic cost and preferred speed of walking in obese vs. normal weight women</article-title><source>Obes Res</source><year>2005</year><volume>13</volume><issue>5</issue><fpage>891</fpage><lpage>899</lpage><comment>
<ext-link xlink:href="https://onlinelibrary.wiley.com/doi/10.1038/oby.2005.103" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1038/oby.2005.103</pub-id><pub-id pub-id-type="medline">15919843</pub-id><pub-id pub-id-type="pii">13/5/891</pub-id><pub-id pub-id-type="pmid">15919843</pub-id>
</element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williamson</surname><given-names>DA</given-names></name><name><surname>Bray</surname><given-names>GA</given-names></name><name><surname>Ryan</surname><given-names>DH</given-names></name></person-group><article-title>Is 5% weight loss a satisfactory criterion to define clinically significant weight loss?</article-title><source>Obesity (Silver Spring)</source><year>2015</year><volume>23</volume><issue>12</issue><fpage>2319</fpage><lpage>2320</lpage><comment>
<ext-link xlink:href="https://onlinelibrary.wiley.com/doi/10.1002/oby.21358" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1002/oby.21358</pub-id><pub-id pub-id-type="medline">26523739</pub-id><pub-id pub-id-type="pmid">26523739</pub-id>
</element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reily</surname><given-names>NM</given-names></name><name><surname>Pinkus</surname><given-names>RT</given-names></name><name><surname>Vartanian</surname><given-names>LR</given-names></name><name><surname>Faasse</surname><given-names>K</given-names></name></person-group><article-title>Compensatory eating after exercise in everyday life: insights from daily diary studies</article-title><source>PLoS One</source><year>2023</year><volume>18</volume><issue>3</issue><fpage>e0282501</fpage><comment>
<ext-link xlink:href="https://dx.plos.org/10.1371/journal.pone.0282501" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1371/journal.pone.0282501</pub-id><pub-id pub-id-type="medline">36920917</pub-id><pub-id pub-id-type="pii">PONE-D-22-32978</pub-id><!--<pub-id pub-id-type="pmcid">PMC10016725</pub-id>--><pub-id pub-id-type="pmid">36920917</pub-id>
</element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fedewa</surname><given-names>MV</given-names></name><name><surname>Hathaway</surname><given-names>ED</given-names></name><name><surname>Williams</surname><given-names>TD</given-names></name><name><surname>Schmidt</surname><given-names>MD</given-names></name></person-group><article-title>Effect of exercise training on non-exercise physical activity: a systematic review and meta-analysis of randomized controlled trials</article-title><source>Sports Med</source><year>2017</year><volume>47</volume><issue>6</issue><fpage>1171</fpage><lpage>1182</lpage><pub-id pub-id-type="doi">10.1007/s40279-016-0649-z</pub-id><pub-id pub-id-type="medline">27873191</pub-id><pub-id pub-id-type="pii">10.1007/s40279-016-0649-z</pub-id><pub-id pub-id-type="pmid">27873191</pub-id>
</element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vetrovsky</surname><given-names>T</given-names></name><name><surname>Omcirk</surname><given-names>D</given-names></name><name><surname>Malecek</surname><given-names>J</given-names></name><name><surname>Stastny</surname><given-names>P</given-names></name><name><surname>Steffl</surname><given-names>M</given-names></name><name><surname>Tufano</surname><given-names>JJ</given-names></name></person-group><article-title>Morning fatigue and structured exercise interact to affect non-exercise physical activity of fit and healthy older adults</article-title><source>BMC Geriatr</source><year>2021</year><volume>21</volume><issue>1</issue><fpage>179</fpage><comment>
<ext-link xlink:href="https://bmcgeriatr.biomedcentral.com/articles/10.1186/s12877-021-02131-y" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1186/s12877-021-02131-y</pub-id><pub-id pub-id-type="medline">33711945</pub-id><pub-id pub-id-type="pii">10.1186/s12877-021-02131-y</pub-id><!--<pub-id pub-id-type="pmcid">PMC7953813</pub-id>--><pub-id pub-id-type="pmid">33711945</pub-id>
</element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stechova</surname><given-names>K</given-names></name><name><surname>Hlubik</surname><given-names>J</given-names></name><name><surname>Pithova</surname><given-names>P</given-names></name><name><surname>Cikl</surname><given-names>P</given-names></name><name><surname>Lhotska</surname><given-names>L</given-names></name></person-group><article-title>Comprehensive analysis of the real lifestyles of T1D patients for the purpose of designing a personalized counselor for prandial insulin dosing</article-title><source>Nutrients</source><year>2019</year><volume>11</volume><issue>5</issue><fpage>1148</fpage><comment>
<ext-link xlink:href="https://www.mdpi.com/resolver?pii=nu11051148" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.3390/nu11051148</pub-id><pub-id pub-id-type="medline">31126048</pub-id><pub-id pub-id-type="pii">nu11051148</pub-id><!--<pub-id pub-id-type="pmcid">PMC6567095</pub-id>--><pub-id pub-id-type="pmid">31126048</pub-id>
</element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rowlands</surname><given-names>AV</given-names></name><name><surname>Edwardson</surname><given-names>CL</given-names></name><name><surname>Davies</surname><given-names>MJ</given-names></name><name><surname>Khunti</surname><given-names>K</given-names></name><name><surname>Harrington</surname><given-names>DM</given-names></name><name><surname>Yates</surname><given-names>T</given-names></name></person-group><article-title>Beyond cut points: accelerometer metrics that capture the physical activity profile</article-title><source>Med Sci Sports Exerc</source><year>2018</year><volume>50</volume><issue>6</issue><fpage>1323</fpage><lpage>1332</lpage><comment>
<ext-link xlink:href="https://strathprints.strath.ac.uk/76105/" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1249/MSS.0000000000001561</pub-id><pub-id pub-id-type="medline">29360664</pub-id><pub-id pub-id-type="pmid">29360664</pub-id>
</element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>AW</given-names></name><name><surname>Tetzlaff</surname><given-names>JM</given-names></name><name><surname>Altman</surname><given-names>DG</given-names></name><name><surname>Laupacis</surname><given-names>A</given-names></name><name><surname>G&#x000f8;tzsche</surname><given-names>PC</given-names></name><name><surname>Krle&#x0017e;a-Jeri&#x00107;</surname><given-names>K</given-names></name><name><surname>Hr&#x000f3;bjartsson</surname><given-names>A</given-names></name><name><surname>Mann</surname><given-names>H</given-names></name><name><surname>Dickersin</surname><given-names>K</given-names></name><name><surname>Berlin</surname><given-names>JA</given-names></name><name><surname>Dor&#x000e9;</surname><given-names>CJ</given-names></name><name><surname>Parulekar</surname><given-names>WR</given-names></name><name><surname>Summerskill</surname><given-names>WSM</given-names></name><name><surname>Groves</surname><given-names>T</given-names></name><name><surname>Schulz</surname><given-names>KF</given-names></name><name><surname>Sox</surname><given-names>HC</given-names></name><name><surname>Rockhold</surname><given-names>FW</given-names></name><name><surname>Rennie</surname><given-names>D</given-names></name><name><surname>Moher</surname><given-names>D</given-names></name></person-group><article-title>SPIRIT 2013 statement: defining standard protocol items for clinical trials</article-title><source>Ann Intern Med</source><year>2013</year><volume>158</volume><issue>3</issue><fpage>200</fpage><lpage>207</lpage><comment>
<ext-link xlink:href="https://www.acpjournals.org/doi/abs/10.7326/0003-4819-158-3-201302050-00583?url_ver=Z39.88-2003&#x00026;rfr_id=ori:rid:crossref.org&#x00026;rfr_dat=cr_pub0pubmed" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.7326/0003-4819-158-3-201302050-00583</pub-id><pub-id pub-id-type="medline">23295957</pub-id><pub-id pub-id-type="pii">1556168</pub-id><!--<pub-id pub-id-type="pmcid">PMC5114123</pub-id>--><pub-id pub-id-type="pmid">23295957</pub-id>
</element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>J</given-names></name><name><surname>Alwan</surname><given-names>NA</given-names></name><name><surname>West</surname><given-names>J</given-names></name><name><surname>Brown</surname><given-names>S</given-names></name><name><surname>McKinlay</surname><given-names>CJ</given-names></name><name><surname>Farrar</surname><given-names>D</given-names></name><name><surname>Crowther</surname><given-names>CA</given-names></name></person-group><article-title>Lifestyle interventions for the treatment of women with gestational diabetes</article-title><source>Cochrane Database Syst Rev</source><year>2017</year><volume>5</volume><issue>5</issue><fpage>CD011970</fpage><comment>
<ext-link xlink:href="https://europepmc.org/abstract/MED/28472859" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1002/14651858.CD011970.pub2</pub-id><pub-id pub-id-type="medline">28472859</pub-id><!--<pub-id pub-id-type="pmcid">PMC6481373</pub-id>--><pub-id pub-id-type="pmid">28472859</pub-id>
</element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name></person-group><article-title>The effectiveness of lifestyle interventions for diabetes remission on patients with type 2 diabetes mellitus: a&#x000a0;systematic review and meta-analysis</article-title><source>Worldviews Evid Based Nurs</source><year>2023</year><volume>20</volume><issue>1</issue><fpage>64</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1111/wvn.12608</pub-id><pub-id pub-id-type="medline">36480153</pub-id><pub-id pub-id-type="pmid">36480153</pub-id>
</element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zucatti</surname><given-names>KP</given-names></name><name><surname>Teixeira</surname><given-names>PP</given-names></name><name><surname>Wayerbacher</surname><given-names>LF</given-names></name><name><surname>Piccoli</surname><given-names>GF</given-names></name><name><surname>Correia</surname><given-names>PE</given-names></name><name><surname>Fonseca</surname><given-names>NKO</given-names></name><name><surname>Moresco</surname><given-names>KS</given-names></name><name><surname>Guerra</surname><given-names>BA</given-names></name><name><surname>Madur&#x000e9;</surname><given-names>MG</given-names></name><name><surname>Farenzena</surname><given-names>LP</given-names></name><name><surname>Frankenberg</surname><given-names>AD</given-names></name><name><surname>Brietzke</surname><given-names>E</given-names></name><name><surname>Halpern</surname><given-names>B</given-names></name><name><surname>Franco</surname><given-names>O</given-names></name><name><surname>Colpani</surname><given-names>V</given-names></name><name><surname>Gerchman</surname><given-names>F</given-names></name></person-group><article-title>Long-term effect of lifestyle interventions on the cardiovascular and all-cause mortality of subjects with prediabetes and type 2 diabetes: A systematic review and meta-analysis</article-title><source>Diabetes Care</source><year>2022</year><volume>45</volume><issue>11</issue><fpage>2787</fpage><lpage>2795</lpage><comment>
<ext-link xlink:href="https://boris.unibe.ch/id/eprint/174412" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.2337/dc22-0642</pub-id><pub-id pub-id-type="medline">36318674</pub-id><pub-id pub-id-type="pii">147815</pub-id><pub-id pub-id-type="pmid">36318674</pub-id>
</element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schellenberg</surname><given-names>ES</given-names></name><name><surname>Dryden</surname><given-names>DM</given-names></name><name><surname>Vandermeer</surname><given-names>B</given-names></name><name><surname>Ha</surname><given-names>C</given-names></name><name><surname>Korownyk</surname><given-names>C</given-names></name></person-group><article-title>Lifestyle interventions for patients with and at risk for type 2 diabetes: a systematic review and meta-analysis</article-title><source>Ann Intern Med</source><year>2013</year><volume>159</volume><issue>8</issue><fpage>543</fpage><lpage>551</lpage><comment>
<ext-link xlink:href="https://www.acpjournals.org/doi/abs/10.7326/0003-4819-159-8-201310150-00007?url_ver=Z39.88-2003&#x00026;rfr_id=ori:rid:crossref.org&#x00026;rfr_dat=cr_pub0pubmed" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.7326/0003-4819-159-8-201310150-00007</pub-id><pub-id pub-id-type="medline">24126648</pub-id><pub-id pub-id-type="pii">1748845</pub-id><pub-id pub-id-type="pmid">24126648</pub-id>
</element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>da Rocha</surname><given-names>RB</given-names></name><name><surname>Silva</surname><given-names>CS</given-names></name><name><surname>Cardoso</surname><given-names>VS</given-names></name></person-group><article-title>Self-care in adults with type 2 diabetes mellitus: A systematic review</article-title><source>Curr Diabetes Rev</source><year>2020</year><volume>16</volume><issue>6</issue><fpage>598</fpage><lpage>607</lpage><pub-id pub-id-type="doi">10.2174/1573399815666190702161849</pub-id><pub-id pub-id-type="medline">31267873</pub-id><pub-id pub-id-type="pii">CDR-EPUB-99351</pub-id><pub-id pub-id-type="pmid">31267873</pub-id>
</element-citation></ref></ref-list></back></article>